AMAG Pharma (AMAG) Posts Q3 Loss of $1.88/Sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Tech stocks pull Wall Street lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
AMAG Pharmaceuticals (AMAG) PT Lowered to $20 at Piper Jaffray
November 1, 2018 1:20 PM EDTPiper Jaffray analyst Christopher Raymond lowered the price target on AMAG Pharmaceuticals (NASDAQ: AMAG) to $20.00 (from $22.00) while maintaining a Neutral rating.
Raymond said the 2019 guidance was a 'bit of a bombshell'.
... MoreAMAG Pharmaceuticals (AMAG) PT Lowered to $19 at Cowen
November 1, 2018 12:43 PM EDTCowen analyst Ken Cacciatore lowered the price target on AMAG Pharmaceuticals (NASDAQ: AMAG) to $19.00 (from $25.00) while maintaining a Market Perform rating following results.
Cacciatore notes the company is taking an aggressive and understandable approach of investing in their current new product cycle.
... More